ObjectiveRecurrent and metastatic tumors of the head and neck pose significant treatment challenges due to their proximity to critical structures and prior radiation exposure. This study aimed to eval
sheet "doses": tumor dose distributions obtained from 90Y TOF-PET post selective internal radio-nuclide therapy (SIRT) and total lesion metabolism (TLM) variation measured using 11C-acetate or 18F-FDG
This study aimed to evaluate the dosimetric benefits of magnetic resonance (MR)-guided radiotherapy (MRgRT) compared to computed tomography (CT)-guided RT for partial breast treatment. First, treatmen
